Literature DB >> 1516785

Accumulation of Cd(II) in the CNS depending on the route of administration: intraperitoneal, intratracheal, or intranasal.

J Evans1, L Hastings.   

Abstract

The uptake and subsequent neuronal transport of certain heavy metals in the olfactory mucosa may be a major means by which these compounds gain access to the CNS. To contrast olfactory versus blood-borne routes of exposure, three groups (n = 4) of adult Long-Evans rats were exposed to solutions of radiolabeled CdCl2. Exposure was by one of three routes: unilateral intranasal instillation (IN), intratracheal lavage (IT), or intraperitoneal injection (ip). The dose level for the intranasal route was 30 microliters of 1 microM CdCl2 labeled with 1 microCi 109Cd. For IT and ip, the dose was 30 microliters of 1 microM CdCl2 diluted to 300 microliters in saline and labeled with 1 microCi 109Cd. Rats were euthanized 24 hr after exposure, tissue samples were taken, and radioactivity was counted. Cd levels were low in the olfactory bulbs of rats exposed either intratracheally or intraperitoneally. However, in rats intranasally exposed, Cd levels were nearly 40 x higher in olfactory bulbs ipsilateral to the exposed side than in those on the contralateral side. With all routes of exposure, Cd levels in brain samples were only slightly elevated. These results suggest that for certain airborne toxicants, especially those that are excluded from the CNS by the blood-brain barrier, the olfactory system may provide a direct route of entry into the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516785     DOI: 10.1016/0272-0590(92)90161-a

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  8 in total

1.  Functional rehabilitation of cadmium-induced neurotoxicity despite persistent peripheral pathophysiology in the olfactory system.

Authors:  Lindsey A Czarnecki; Andrew H Moberly; Daniel J Turkel; Tom Rubinstein; Joseph Pottackal; Michelle C Rosenthal; Elizabeth F K McCandlish; Brian Buckley; John P McGann
Journal:  Toxicol Sci       Date:  2012-01-27       Impact factor: 4.849

2.  In vivo visualization of olfactory pathophysiology induced by intranasal cadmium instillation in mice.

Authors:  Lindsey A Czarnecki; Andrew H Moberly; Tom Rubinstein; Daniel J Turkel; Joseph Pottackal; John P McGann
Journal:  Neurotoxicology       Date:  2011-04-02       Impact factor: 4.294

3.  Neurobehavioural effects of occupational exposure to cadmium: a cross sectional epidemiological study.

Authors:  M K Viaene; R Masschelein; J Leenders; M De Groof; L J Swerts; H A Roels
Journal:  Occup Environ Med       Date:  2000-01       Impact factor: 4.402

Review 4.  Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals.

Authors:  I R Bell; J Rossi; M E Gilbert; G Kobal; L A Morrow; D B Newlin; B A Sorg; R W Wood
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

5.  Cadmium and Alzheimer's disease mortality in U.S. adults: Updated evidence with a urinary biomarker and extended follow-up time.

Authors:  Qing Peng; Kelly M Bakulski; Bin Nan; Sung Kyun Park
Journal:  Environ Res       Date:  2017-05-13       Impact factor: 6.498

6.  P-Glycoprotein attenuates brain uptake of substrates after nasal instillation.

Authors:  Candace L Graff; Gary M Pollack
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

7.  Calcium Signaling Involvement in Cadmium-Induced Astrocyte Cytotoxicity and Cell Death Through Activation of MAPK and PI3K/Akt Signaling Pathways.

Authors:  Jiao Hua Jiang; Guo Ge; Kai Gao; Ying Pang; Rui Chao Chai; Xi Hua Jia; Jin Ge Kong; Albert Cheung-Hoi Yu
Journal:  Neurochem Res       Date:  2015-08-07       Impact factor: 3.996

8.  Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice.

Authors:  Yoshiko Fukuyama; Kazunari Okada; Masahiro Yamaguchi; Hiroshi Kiyono; Kensaku Mori; Yoshikazu Yuki
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.